YAP1 and nonpapillary renal cell carcinoma: If Yap activation inhibits ccRCC cancer cell growth in 2D cultures by impeding p65/ZHX2 cooperativity, one would predict that increasing the level of either ZHX2 or p65 may rescue ccRCC cancer cell growth inhibited by XMU-MP-1.